• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:类风湿关节炎中血管生成及其介质的靶向分子成像。

Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.

机构信息

Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

出版信息

Int J Mol Sci. 2022 Jun 25;23(13):7071. doi: 10.3390/ijms23137071.

DOI:10.3390/ijms23137071
PMID:35806074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267012/
Abstract

Extensive angiogenesis is a characteristic feature in the synovial tissue of rheumatoid arthritis (RA) from a very early stage of the disease onward and constitutes a crucial event for the development of the proliferative synovium. This process is markedly intensified in patients with prolonged disease duration, high disease activity, disease severity, and significant inflammatory cell infiltration. Angiogenesis is therefore an interesting target for the development of new therapeutic approaches as well as disease monitoring strategies in RA. To this end, nuclear imaging modalities represent valuable non-invasive tools that can selectively target molecular markers of angiogenesis and accurately and quantitatively track molecular changes in multiple joints simultaneously. This systematic review summarizes the imaging markers used for single photon emission computed tomography (SPECT) and/or positron emission tomography (PET) approaches, targeting pathways and mediators involved in synovial neo-angiogenesis in RA.

摘要

广泛的血管生成是类风湿关节炎(RA)滑膜组织的一个特征,从疾病的早期阶段开始,并且是增生性滑膜发展的关键事件。在疾病持续时间长、疾病活动度高、疾病严重程度和炎症细胞浸润显著的患者中,这一过程明显加剧。因此,血管生成是开发新的治疗方法以及 RA 疾病监测策略的一个有趣的靶点。为此,核成像方式代表了有价值的非侵入性工具,可以选择性地针对血管生成的分子标记物,并准确和定量地同时跟踪多个关节中的分子变化。本系统综述总结了用于单光子发射计算机断层扫描(SPECT)和/或正电子发射断层扫描(PET)方法的成像标记物,这些方法针对 RA 滑膜中新血管生成涉及的途径和介质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/8aa2e34d63e6/ijms-23-07071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/5afbbf4d58de/ijms-23-07071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/6fedd302d960/ijms-23-07071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/8aa2e34d63e6/ijms-23-07071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/5afbbf4d58de/ijms-23-07071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/6fedd302d960/ijms-23-07071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f1/9267012/8aa2e34d63e6/ijms-23-07071-g003.jpg

相似文献

1
Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.系统评价:类风湿关节炎中血管生成及其介质的靶向分子成像。
Int J Mol Sci. 2022 Jun 25;23(13):7071. doi: 10.3390/ijms23137071.
2
What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.超声关节检查在监测类风湿关节炎滑膜炎方面的附加值是什么,它能否用于指导治疗决策?系统评价和成本效益分析。
Health Technol Assess. 2018 Apr;22(20):1-258. doi: 10.3310/hta22200.
3
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
4
Novel positron emission tomography tracers for imaging of rheumatoid arthritis.用于类风湿关节炎成像的新型正电子发射断层扫描示踪剂。
Autoimmun Rev. 2021 Mar;20(3):102764. doi: 10.1016/j.autrev.2021.102764. Epub 2021 Jan 19.
5
Rofecoxib for rheumatoid arthritis.用于类风湿性关节炎的罗非昔布
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD003685. doi: 10.1002/14651858.CD003685.pub2.
6
The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.使用模型评估针对慢性病患者的新药:以类风湿关节炎中抗肿瘤坏死因子抗体为例。
Health Technol Assess. 2004 Mar;8(11):iii, 1-91. doi: 10.3310/hta8110.
7
Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis.低强度激光疗法(I、II和III类)治疗类风湿性关节炎
Cochrane Database Syst Rev. 2000(2):CD002049. doi: 10.1002/14651858.CD002049.
8
Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.氟-18-氟代脱氧葡萄糖(FDG)正电子发射断层扫描(PET)计算机断层扫描(CT)用于检测横纹肌肉瘤中的骨、肺和淋巴结转移。
Cochrane Database Syst Rev. 2021 Nov 9;11(11):CD012325. doi: 10.1002/14651858.CD012325.pub2.
9
Rheumatology in the era of precision medicine: synovial tissue molecular patterns and treatment response in rheumatoid arthritis.精准医学时代的风湿病学:类风湿关节炎的滑膜组织分子图谱和治疗反应。
Curr Opin Rheumatol. 2021 Jan;33(1):58-63. doi: 10.1097/BOR.0000000000000767.
10
Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis.用于治疗类风湿性关节炎的低强度激光疗法(I、II和III类)
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD002049. doi: 10.1002/14651858.CD002049.pub2.

引用本文的文献

1
Effects and molecular mechanisms of Blume and K.C. Kuan in the treatment of rheumatoid arthritis.金沸草与宽叶缬草治疗类风湿关节炎的作用及分子机制
Front Pharmacol. 2025 Jul 24;16:1619776. doi: 10.3389/fphar.2025.1619776. eCollection 2025.
2
The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.类风湿关节炎与血栓形成的炎症关联:致病分子机制及治疗方法
Curr Issues Mol Biol. 2025 Apr 18;47(4):291. doi: 10.3390/cimb47040291.
3
Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein.

本文引用的文献

1
Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.含RGD肽作为PET肿瘤显像剂的初步临床应用
Front Oncol. 2022 Mar 2;12:837952. doi: 10.3389/fonc.2022.837952. eCollection 2022.
2
Novel synovial targeting peptide-sinomenine conjugates as a potential strategy for the treatment of rheumatoid arthritis.新型滑膜靶向肽-青藤碱缀合物治疗类风湿关节炎的潜在策略。
Int J Pharm. 2022 Apr 5;617:121628. doi: 10.1016/j.ijpharm.2022.121628. Epub 2022 Mar 1.
3
Challenging the Paradigm: Anti-Inflammatory Interleukins and Angiogenesis.
成像配体亲水性的增加和药代动力学性质的改善,增强了对成纤维细胞活化蛋白的体内靶向作用。
Npj Imaging. 2024 Aug 2;2(1):24. doi: 10.1038/s44303-024-00028-0.
4
Angiogenesis in rheumatoid Arthritis: Pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies.类风湿关节炎中的血管生成:病理特征、致病机制及纳米靶向治疗策略
Bioact Mater. 2025 May 2;50:603-639. doi: 10.1016/j.bioactmat.2025.04.026. eCollection 2025 Aug.
5
The distinct transcriptomic signature of the resolution phase fibroblast-like synoviocytes supports endothelial cell dysfunction.消退期成纤维细胞样滑膜细胞独特的转录组特征支持内皮细胞功能障碍。
Commun Biol. 2025 May 30;8(1):837. doi: 10.1038/s42003-025-08250-1.
6
Bibliometric analysis of research hotspots and trends of lncRNA in angiogenesis-related diseases.血管生成相关疾病中lncRNA研究热点与趋势的文献计量分析
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Dec 28;49(12):1953-1965. doi: 10.11817/j.issn.1672-7347.2024.240138.
7
Unveiling the Anti-Angiogenic Potential of Small-Molecule (Kinase) Inhibitors for Application in Rheumatoid Arthritis.揭示小分子(激酶)抑制剂在类风湿关节炎中的抗血管生成潜力及应用
Cells. 2025 Jan 11;14(2):102. doi: 10.3390/cells14020102.
8
Dual targeting heterodimer PET tracer [F]AlF‑FAPI‑RGD in patients with rheumatoid arthritis: a pilot exploratory study.双靶点异二聚体PET示踪剂[F]AlF-FAPI-RGD在类风湿关节炎患者中的初步探索性研究
Theranostics. 2024 Oct 21;14(18):7042-7053. doi: 10.7150/thno.102627. eCollection 2024.
9
Application of superb microvascular imaging technology in clinical disease activity of rheumatoid arthritis.高超微血管成像技术在类风湿关节炎临床疾病活动中的应用。
Clin Rheumatol. 2024 Nov;43(11):3293-3300. doi: 10.1007/s10067-024-07119-8. Epub 2024 Sep 12.
10
Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.治疗性靶向纤维连接蛋白在自身免疫和纤维化应用中的递药技术。
Adv Drug Deliv Rev. 2024 Jun;209:115303. doi: 10.1016/j.addr.2024.115303. Epub 2024 Apr 6.
挑战传统观念:抗炎细胞因子与血管生成。
Cells. 2022 Feb 8;11(3):587. doi: 10.3390/cells11030587.
4
Galectin expression detected by Ga-galectracer PET as a predictive biomarker of radiotherapy resistance.Galectin 表达通过 Ga-galectracer PET 检测作为预测放疗抵抗的生物标志物。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2746-2760. doi: 10.1007/s00259-022-05711-1. Epub 2022 Feb 2.
5
Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 68Ga-DOTANOC PET/computed tomography in articular manifestation of rheumatoid arthritis.99mTc-甲基双膦酸盐骨闪烁显像与 68Ga-DOTANOC PET/CT 对类风湿关节炎关节表现的比较。
Nucl Med Commun. 2022 Apr 1;43(4):428-432. doi: 10.1097/MNM.0000000000001532.
6
Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147.托珠单抗(TCZ)通过调节 miR-146a-5p 和 EMMPRIN/CD147 抑制血管生成从而治疗类风湿关节炎。
Front Immunol. 2021 Dec 15;12:739592. doi: 10.3389/fimmu.2021.739592. eCollection 2021.
7
New Radionuclides and Technological Advances in SPECT and PET Scanners.SPECT和PET扫描仪中的新型放射性核素与技术进展
Cancers (Basel). 2021 Dec 8;13(24):6183. doi: 10.3390/cancers13246183.
8
One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for Tc radiolabelling of peptides.一步法、试剂盒型放射性药物用于分子 SPECT 成像:一种用于 Tc 标记肽的多功能双膦配体。
Dalton Trans. 2021 Nov 16;50(44):16156-16165. doi: 10.1039/d1dt03177e.
9
Hybrid total-body pet scanners-current status and future perspectives.混合式全身 PET 扫描仪:现状与未来展望。
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):445-459. doi: 10.1007/s00259-021-05536-4. Epub 2021 Oct 14.
10
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography.αvβ3整合素之外的世界:用于正电子发射断层扫描成像整合素亚型αvβ6、αvβ8、αvβ3和α5β1的多聚体配体
EJNMMI Res. 2021 Oct 12;11(1):106. doi: 10.1186/s13550-021-00842-2.